HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephen Paul Berger Selected Research

1-hydroxy-3-amino-2-pyrrolidone

1/2008Sigma ligands, but not N-methyl-D-aspartate antagonists, reduce levodopa-induced dyskinesias.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stephen Paul Berger Research Topics

Disease

1Parkinson Disease (Parkinson's Disease)
01/2008
1Dyskinesias (Dyskinesia)
01/2008

Drug/Important Bio-Agent (IBA)

11-hydroxy-3-amino-2-pyrrolidoneIBA
01/2008
1alpha- (4- fluorophenyl)- 4- (5- fluoro- 2- pyrimidinyl)- 1- piperazine butanolIBA
01/2008
1Amantadine (Aman)FDA LinkGeneric
01/2008
1Dextromethorphan (Racemethorphan)FDA LinkGeneric
01/2008
1Levodopa (L Dopa)FDA LinkGeneric
01/2008
1LigandsIBA
01/2008
1N-Methylaspartate (NMDA)IBA
01/2008
1Dizocilpine Maleate (Dizocilpine)IBA
01/2008
1Oxidopamine (6 Hydroxydopamine)IBA
01/2008